Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
228
datasets available to search
ShareScore release 0.9.0
Dataset results
228 results for “Immunotherapy targets”
A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (
ClinicalTrials.gov study NCT05276297. IPD Sharing: YES. Countries: 15. Publications: 0.
Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Lo
ClinicalTrials.gov study NCT05611229. IPD Sharing: NO. Countries: 1. Publications: 0.
Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04152356. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA with High Risk T-Cell ALL & Lymphoma
ClinicalTrials.gov study NCT04972942. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT04715217. IPD Sharing: YES. Countries: 1. Publications: 0.
From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy
ClinicalTrials.gov study NCT06273878. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer
ClinicalTrials.gov study NCT04163237. IPD Sharing: YES. Countries: 1. Publications: 0.
Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06470256. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent
ClinicalTrials.gov study NCT05298254. IPD Sharing: YES. Countries: 8. Publications: 0.
A Study of BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04182581. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue Sarcoma
ClinicalTrials.gov study NCT06062927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT06322095. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC
ClinicalTrials.gov study NCT06699498. IPD Sharing: NO. Countries: 1. Publications: 0.
Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma
ClinicalTrials.gov study NCT06718257. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer
ClinicalTrials.gov study NCT05904080. IPD Sharing: YES. Countries: 1. Publications: 0.
Development of a LRRC15-Targeted Radio-immunotheranostic Approach to Deplete Pro-tumorigenic Mechanisms and Immunotherapy Resistance
GEO Series GSE260644. Homo sapiens. 64 samples. Type: Expression profiling by high throughput sequencing.
Targeting TREM2 on tumor associated macrophages enhances efficacious immunotherapy
GEO Series GSE165404. Homo sapiens; Mus musculus. 15 samples. Type: Expression profiling by high throughput sequencing.
A tumor-associated macrophage-targeted immunocytokine leveraging T and NK cell synergy for potent cancer immunotherapy [CITE-seq]
GEO Series GSE303868. Homo sapiens. 36 samples. Type: Expression profiling by high throughput sequencing; Other.
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy [TCR-seq]
GEO Series GSE228884. Mus musculus. 16 samples. Type: Other.
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
GEO Series GSE214585. Mus musculus; Homo sapiens. 40 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.